| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 01/07/2015 | CN102977534B 海藻酸钠与聚双丙酮丙烯酰胺互穿网络凝胶的制备 Preparation of alginate and poly diacetoneacrylamide IPN gel |
| 01/07/2015 | CN102971013B 缀合的凝血因子VIIa Conjugated Factor VIIa |
| 01/07/2015 | CN102961750B 二氧化硅气凝胶在制药中的应用 Silica airgel applications in pharmacy |
| 01/07/2015 | CN102784128B 一种非洛地平缓释制剂及其制备方法 One kind of felodipine and its preparation method |
| 01/07/2015 | CN102741317B 蛋白,多肽或肽药物递送用高分子及其制备方法,及蛋白,多肽或肽药物的缓释型组合物及其制备方法 Proteins, peptides or peptide drug delivery polymer and its preparation method used, and proteins, peptides or peptide drug sustained-release composition and its preparation method |
| 01/07/2015 | CN102600141B 含有阿莫西林和克拉维酸钾的分散片 Containing amoxicillin and clavulanate potassium tablet |
| 01/07/2015 | CN102512659B 一种含有棘白菌素类抗真菌剂的药用组合物及其制备方法和用途 Containing echinocandin antifungal pharmaceutical composition and its preparation method and use |
| 01/07/2015 | CN102482685B 包括多核苷酸剂的细胞靶向纳米颗粒及其应用 Including cell polynucleotide agents targeted nanoparticles and its application |
| 01/07/2015 | CN102131509B 聚合物、二膦酸盐和抗血管生成剂的缀合物及其在治疗和监测骨相关疾病中的用途 Polymer, bisphosphonates and anti-angiogenesis agent conjugates and their use in the treatment and monitoring of bone related diseases |
| 01/07/2015 | CN102008476B 一种马钱子碱的羟丙基-β-环糊精包合物及其制备方法 One kind of strychnine hydroxypropyl cyclodextrin inclusion -β- its preparation method |
| 01/07/2015 | CN101953816B 药用空心胶囊、制备方法及其制造设备 Medicinal hollow capsules, preparation and manufacturing equipment |
| 01/07/2015 | CN101891825B 乙肝核心蛋白与结核抗原或抗原片段的重组融合蛋白及用途 Hepatitis B core protein and recombinant tuberculosis antigens or antigen fusion protein fragments and uses |
| 01/07/2015 | CN101774599B 一种改性钠基蒙脱石、其制备方法和用途 A modified sodium montmorillonite, their preparation and use |
| 01/06/2015 | US8927716 Benzoic acid, benzoic acid derivatives and heteroaryl carboxylic acid conjugates of hydrocodone, prodrugs, methods of making and use thereof |
| 01/06/2015 | US8927609 Co-attrited stabilizer composition |
| 01/06/2015 | US8927606 Aqueous liquid preparation containing 2-amino-3-(4-bromobenzoyl)phenylacetic acid |
| 01/06/2015 | US8927604 Diclofenac formulations and methods of use |
| 01/06/2015 | US8927537 Patches, formulations, and associated methods for transdermal delivery of alprazolam and other drugs |
| 01/06/2015 | US8927529 Treatment of back pain by injection of microparticles of dexamethasone acetate and a polymer |
| 01/06/2015 | US8927524 Sterile alginate-based aqueous composition for medical use and process for the preparation thereof |
| 01/06/2015 | US8927512 RNA aptamer specifically binding to carcinoembryonic antigen and use thereof |
| 01/06/2015 | US8927502 Embedded chimeric peptide nucleic acids and uses thereof |
| 01/06/2015 | US8927495 Use of GnRH and analogs thereof for the prevention and treatment of pet ferret adrenocortical hyperplasia |
| 01/06/2015 | US8927490 Systems and methods to estimate nutritional needs of human and other patients |
| 01/06/2015 | US8927489 Sustained release preparation of pro-insulin C-peptide |
| 01/06/2015 | US8927488 Pegylated C-peptide |
| 01/06/2015 | US8927487 Antimicrobial cationic peptides and formulations thereof |
| 01/06/2015 | US8927486 Compounds |
| 01/06/2015 | US8927485 Site-specific modification of proteins through chemical modification enabling protein conjugates, protein dimer formation, and stapled peptides |
| 01/06/2015 | US8927251 Targeting of herpes simplex virus to specific receptors |
| 01/06/2015 | US8927249 Extended soluble PH20 polypeptides and uses thereof |
| 01/06/2015 | US8927023 Biocompatible, non-biodegradable, non-toxic polymer useful for nanoparticle pharmaceutical compositions |
| 01/06/2015 | US8927020 Method for producing biologically ingestible material and biologically ingestible material obtained therefrom |
| 01/06/2015 | US8927019 Methods and compositions for treating recurrent cancer |
| 01/06/2015 | US8927015 Formulations for delivering insulin |
| 01/06/2015 | US8927011 Method for producing pharmaceutical tablet |
| 01/06/2015 | US8927009 ABT-263 capsule |
| 01/06/2015 | US8927006 Methods and compositions for rapid treatment of otitis externa |
| 01/06/2015 | US8927005 Liquid formulations for treatment of diseases or conditions |
| 01/06/2015 | US8926994 Mesoporous silicon particles for the presentation of tumor antigens and adjuvant for anti-cancer immunity |
| 01/06/2015 | US8926986 Use of saccharides cross-reactive with Bacillus anthracis spore glycoprotein as a vaccine against anthrax |
| 01/06/2015 | US8926973 Reducing the immunogenicity of fusion proteins |
| 01/06/2015 | US8926955 Synthesis of polymer conjugates of indolocarbazole compounds |
| 01/06/2015 | US8926948 Process and apparatus for preparing a diagnostic or therapeutic agent |
| 01/06/2015 | US8926947 Polyol and polyether iron oxide complexes as pharmacological and/or MRI contrast agents |
| 01/06/2015 | US8926946 Peptides for transport of therapeutics and their carriers in mouse models and humans |
| 01/06/2015 | US8926595 Devices, formulations, and methods for delivery of multiple beneficial agents |
| 01/06/2015 | CA2770411C Aerosol containing a particulate active substance |
| 01/06/2015 | CA2767129C Compositions and methods for silencing apolipoprotein b |
| 01/06/2015 | CA2737543C Composite organic compound powder for medical use and production method and suspension of the same |
| 01/06/2015 | CA2642847C Dissolution aids for oral peptide delivery comprising a biguanide |
| 01/06/2015 | CA2630771C Protein constructs designed for targeting and lysis of cells |
| 01/06/2015 | CA2617185C Skin coating composition and uses thereof |
| 01/06/2015 | CA2477935C Multivalent constructs for therapeutic and diagnostic applications |
| 01/06/2015 | CA2446083C Composition and methods for treatment of hyperplasia |
| 01/06/2015 | CA2367357C Method |
| 01/01/2015 | US20150005744 Devices for the treatment of vascular aneurysm |
| 01/01/2015 | US20150005477 Compositions and methods for conjugating activatable antibodies |
| 01/01/2015 | US20150005394 Devices and methods and agent-assisted medical procedures |
| 01/01/2015 | US20150005380 Gelling Formulation Based On Calcium Gluconate |
| 01/01/2015 | US20150005376 Concentrate esmolol |
| 01/01/2015 | US20150005363 Branched Alkyl And Cycloalkyl Terminated Biodegradable Lipids For The Delivery Of Active Agents |
| 01/01/2015 | US20150005341 Pharmaceutical compositions comprising prasugrel and cyclodextrin derivatives and methods of making and using the same |
| 01/01/2015 | US20150005337 Transdermal Delivery Of Systemically Active Central Nervous System Drugs |
| 01/01/2015 | US20150005335 Matrix for sustained, invariant and independent release of active compounds |
| 01/01/2015 | US20150005332 Tamper-resistant pharmaceutical compositions of opioids and other drugs |
| 01/01/2015 | US20150005331 Pharmaceutical Formulation Containing Gelling Agent |
| 01/01/2015 | US20150005323 Sustained delivery formulations of risperidone compounds |
| 01/01/2015 | US20150005314 Pharmaceutical preparation comprising brexpirazole and substituted beta-cyclodextrin |
| 01/01/2015 | US20150005312 Compositions containing alpha-2-adrenergic agonist components |
| 01/01/2015 | US20150005307 Drug Delivery Technology |
| 01/01/2015 | US20150005272 Methods for reducing or preventing transplant rejection in the eye and intraocular implants for use therefor |
| 01/01/2015 | US20150005271 Controlled release delivery system for nasal applications and method of treatment |
| 01/01/2015 | US20150005270 Compositions for the treatment of gastrointestinal inflammation |
| 01/01/2015 | US20150005244 Pharmaceutical formulations |
| 01/01/2015 | US20150005241 Linaclotide compositions |
| 01/01/2015 | US20150005230 Cyclodextrin-based polymers for therapeutic delivery |
| 01/01/2015 | US20150004258 Pharmaceutical composition containing nitrate source and an acidifying agent for treating skin ischaemia |
| 01/01/2015 | US20150004257 Materials for modulating biological responses and methods of making |
| 01/01/2015 | US20150004249 Insulin-mimetic local therapeutic adjuncts for enhancing spinal fusion |
| 01/01/2015 | US20150004240 Compositions and methods of making rapidly dissolving ionically masked formulations |
| 01/01/2015 | US20150004239 Pharmaceutical compositions and methods for their preparation |
| 01/01/2015 | US20150004238 Emulsions providing stable vitamin compositions and methods of forming compositions thereof |
| 01/01/2015 | US20150004237 Cellulose derivatives for inhibiting crystallization of poorly water-soluble drugs |
| 01/01/2015 | US20150004234 Nanoparticulate compositions and formulations of piperazine compounds |
| 01/01/2015 | US20150004219 Stable liposomes for drug delivery |
| 01/01/2015 | US20150004218 Compositions and methods for immune tolerance induction |
| 01/01/2015 | US20150004216 Method and apparatus for minimizing heat, moisture, and shear damage to medicants and other compositions during incorporation of same with edible films |
| 01/01/2015 | US20150004214 Vaginal ring comprising dhea or dhea sulfate and optionally a release-modulating agent of the active principle, useful to increase the ovarian reserve in women and to relieve symptoms associated with menopause |
| 01/01/2015 | US20150004212 Linear polyesteramides from aminophenolic esters |
| 01/01/2015 | US20150004210 Sustained release formulations comprising gnrh analogues |
| 01/01/2015 | US20150004199 Methods for in situ cell sodding |
| 01/01/2015 | US20150004198 Cyanocobalamin low viscosity aqueous formulations for intranasal delivery |
| 01/01/2015 | US20150004196 Topical drug delivery using phosphatidylcholine |
| 01/01/2015 | US20150004193 Novel dna-origami nanovaccines |
| 01/01/2015 | US20150004192 Recombinant polypeptide for enhancing cell transduction efficiency of a target agent |
| 01/01/2015 | US20150004191 Liquid Vaccines For Multiple Meningococcal Serogroups |
| 01/01/2015 | US20150004167 Dual Variable Domain Immunoglobulin and Uses Thereof |
| 01/01/2015 | US20150004165 Secreted proteins |
| 01/01/2015 | US20150004138 Method of repairing a tissue defect using genipin cross-linked fibrin gels |